Quality Nexgen Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 9.00 M
- Company Age 19 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 8.83 Cr
- Satisfied Charges ₹ 10.34 Cr
- Revenue Growth -17.28%
- Profit Growth 315.55%
- Ebitda 73.91%
- Net Worth 12.68%
- Total Assets -12.25%
About Quality Nexgen Pharmaceuticals
Quality Nexgen Pharmaceuticals Private Limited (QNPPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 December 2005 and has a history of 19 years and one month. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.00 M.
The company currently has active open charges totaling ₹8.83 Cr. The company has closed loans amounting to ₹10.34 Cr, as per Ministry of Corporate Affairs (MCA) records.
Santosh Sharma and Shankardayal Sharma serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230MH2005PTC158238
- Company No.
158238
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2005
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Quality Nexgen Pharmaceuticals Private Limited offer?
Quality Nexgen Pharmaceuticals Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs.
Who are the key members and board of directors at Quality Nexgen Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Sharma  | Director | 09-Oct-2020 | Current |
| Shankardayal Sharma | Director | 01-Mar-2012 | Current |
Financial Performance of Quality Nexgen Pharmaceuticals.
Quality Nexgen Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 17.28% decrease. The company also saw a substantial improvement in profitability, with a 315.55% increase in profit. The company's net worth Soared by an impressive increase of 12.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Quality Nexgen Pharmaceuticals?
In 2020, Quality Nexgen Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Quality Intext Private LimitedSantosh Sharma and Shankardayal Sharma are mutual person
Charges (Loans)
₹8.83 Cr
₹10.34 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 7.58 Cr
- Capri Global Capital Limited : 1.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Feb 2014 | Axis Bank Limited | ₹3.68 Cr | Open |
| 10 Dec 2013 | Axis Bank Limited | ₹3.90 Cr | Open |
| 31 Jul 2013 | Capri Global Capital Limited | ₹1.25 Cr | Open |
| 30 Jan 2012 | The Thane Janata Sahakari Bank Ltd | ₹2.30 M | Satisfied |
| 24 Dec 2011 | The Thane Janata Sahakari Bank Ltd. | ₹3.62 Cr | Satisfied |
How Many Employees Work at Quality Nexgen Pharmaceuticals?
Unlock and access historical data on people associated with Quality Nexgen Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Quality Nexgen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quality Nexgen Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
